A phase II B open label randomised controlled trial to evaluate the efficacy and safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with COVID-19 infection (ICE study)
Professor, Christian Medical College (CMC), Vellore
Project Overview
The study aims to understand if the use of Ivermectin is associated with a more rapid clearance of the virus compared to standard supportive treatment and whether this rapid reduction will lead to better outcomes.
Professor, Christian Medical College (CMC), Vellore
Accessibility Controls